GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


Advances in pharmacoepidemiology


Eu2P Short Course: Advances in pharmacoepidemiology

OBJECTIVES

 
Join this advanced hot topic short course, delivered in-person and broadcast live on June 11–12, 2026, during the 14th Bordeaux PharmacoEpi Festival. Download the full program here.

This course will bring you a better knowledge and understanding of:

Advanced Methodological Approaches in Pharmacoepidemiology

  • Comparative effectiveness and safety evaluation in post-marketing surveillance using cutting-edge methodologies (e.g., targeted trial emulation, external control arm, indirect comparisons).
  • Innovative study designs and federated approaches beyond traditional observational studies
  • Application of causal inference methods (e.g., propensity scores, marginal structural models, instrumental variables).
  • Impact of Artificial Intelligence and Machine Learning on Real World Research

Emerging Trends, Regulatory Frameworks, and Global Policy Implications

  • Updates on recent developments in pharmacoepidemiology.
  • How pharmacoepidemiology informs health policy and reimbursement decisions.
  • Cross-continental collaborations and their role in shaping evidence-based medicine.
  • Pharmacoepidemiology and risk prediction toward personalized medicine.

Pharmacoepidemiology, Advanced methodologies, Comparative effectiveness, Drug safety evaluation, Post-marketing surveillance, Real-world evidence (RWE), Real-world data (RWD), Observational studies.

 

LEARNING OUTCOMES

At the end of this course, you will stay abreast of the major news in pharmacoepidemiology as well as hot topics in public health, thanks to this master class format led by international experts.

 

720 minutes
Online based learning
English language
Certificate of Achievement
500 €
BOOK NOW

AUTHORS

avatar

Dr. Shirley Wang

Associate Professor of Medicine
Harvard Medical School

avatar

Pr. Anna-Maija Tolppanen

Professor of Pharmacoepidemiology and real-world data analytics
University of Eastern Finland


avatar

Dr. Tobias Gerhard

Director, Institute for Health, Health Care Policy and Aging Research
Rutgers Health

avatar

Pr. Ulrike Haug

Deputy scientific director for Prevention Research and Epidemiology
Libniz-Institut-BIPS


avatar

Dr. Giorgio Limoncella

Postdoctoral Researcher in Biostatistics
Université de Bordeaux

avatar

Dr. Lianna Ishihara

Senior Director Real World Data Strategy & Partnerships
GlaxoSmithKline Research and Development Ltd




COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Powered By

Eu2P Executive Board partners

Created By

Eu2P project consortium partners